Keros Therapeutics, Inc. (KROS)
NASDAQ·Healthcare·Biotechnology
$9.54
+1.87%
Mkt Cap $230.39M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$20.33
Range $18.00 – $23.00
Implied Upside
+113.2%
Consensus $20.33 vs current $9.54
NASDAQ·Healthcare·Biotechnology
$9.54
+1.87%
Mkt Cap $230.39M
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$20.33
Range $18.00 – $23.00
+113.2%
Consensus $20.33 vs current $9.54